Digital Therapeutics for depression

The first personalized, precision digital therapeutic (DTx) as a video game for depression.

What we do

Our Intervention

Validated in a comprehensive, large scale clinical trial for its effectiveness and safety.

Narrative-driven intervention is engaging, relevant, and impactful.

Tailored to individual needs using precision psychiatry for optimal outcomes.

Seamlessly complements existing treatments.

Our mission

Many individuals with depression face significant barriers to recovery. There is a global need for innovative, effective mental health treatments.

Accessing mental healthcare can be challenging due to stigma, lack of availability, and long waiting times. Moreover, the traditional approaches often fall short for many.

At Soihtu DTx, our mission is to transform mental health care. Founded in 2023 after a decade of scientific research, we harness the games to deliver high-quality, evidence-based digital therapeutics (DTx). We find that games transcend entertainment—they are an engaging, participatory medium that is uniquely suited to empower patients and drive meaningful change in their lives.

By combining cutting-edge science with the power of play, we aim to make mental health care more accessible, effective, and inspiring for everyone who needs it.

Meet the team

Our team uniquely combines neuroscience, psychology, and game development.

The founders are a cross-disciplinary team of serial entrepreneurs with backgrounds from gaming entrepreneurship to academic professorships, clinicians, and PhDs.

Our well-balanced team of eleven has just the right combination of vision, science, tech, design, arts, psychology, and medical knowledge and go-to market experience. Our past experiences give us the tools to build companies, great products, excellent teams, and within the budget.

Prof Matias Palva

Science Lead

Jukka Laakso

Chief Executive Officer

Sami Lehtinen

Chief Technology Officer

Lauri Lukka

Chief Psychology Officer

Joonas J. Juvonen

Chief Data & Analytics Officer

Advisors

World-class advisors in science, medicine and digital therapeutics with relevant industry experience

Prof. Xiaosi Gu

Computational Psychiatry

Professor Xiaosi Gu, PhD, is a trailblazer in computational psychiatry, where her research has illuminated the role of beliefs and decision-making processes behind health and disease. She also serves as Editor-in-Chief of a leading scientific journal and is a passionate advocate for greater mental health awareness and innovation

Acacia Parks, PhD

Regulatory Affairs

Acacia Parks, PhD, is the lead consultant at Liquid Amber, a strategic advisory firm specializing in digital therapeutics. With 20 years of experience in digital health space, Acacia brings a rare blend of deep scientific insight and regulatory strategy expertise, with a proven track record guiding digital health innovations through complex regulatory and reimbursement pathways.

Noah Falstein

Transformational Game Design

Noah Falstein is a true pioneer in the games industry, Noah has shaped the field since the 1980s from his early work at Lucasfilm Games and DreamWorks Interactive, to serving as Chief Game Designer at Google. His mastery of game design is not only legendary, it is foundational to the evolution of games as tools for impact.

Tony J. Simon, PhD

Neurocognitive and DTx Tech

Tony Simon, PhD, brings a unique and invaluable blend of expertise in cognitive neuroscience, game-based therapeutics, and experience from commercialization. His work has helped shape the field, which includes leadership roles in translating neuroscience into an FDA-authorized digital therapeutic, and as Co-Founder, CEO and Chief Science officer of VR-based digital neurotherapeutics company.

Research & Insights